Research SummaryKey Findings

What research findings exist regarding Thymalin in immune regulation?

Partial inflammation and coagulation-related indicators decreased faster after adding Thymalin.[1] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
i

Currently Selected 1 Original Study Related to the Theme of This Page. Fewer than 3 studies, the gap is retained, no other uses are added to fill the number. This page is a purposive collection of positive information, not a systematic review or dosage recommendation. Historical studies, combination formulations, and special models are separately indicated.

Comparison of study design and results

Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.

LiteratureStudy subjects and designObservation and discoveryScope of Explanation
2021 · PMID 33575961Research on adjuvant therapy in COVID-19 patients and cellular mechanismsPartial inflammation and coagulation-related indicators decreased faster after adding Thymalin.Study design and co-treatment limitations; thymus extract mixtures are not equivalent to clearly sequenced single peptides.

References

Human Study2021 · Historical basic researchREF. 01

What changes occur in immune-related markers during combination therapy?

Research Findings

Partial inflammation and coagulation-related indicators decreased faster after adding Thymalin.[1] ↗

Study Design

Research on adjuvant therapy in COVID-19 patients and cellular mechanisms

Scope & Limitations

Study design and co-treatment limitations; thymus extract mixtures are not equivalent to clearly sequenced single peptides.

View the Article Title and Full Citation+

Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.

Khavinson VK, Kuznik BI, Trofimova SV, Volchkov VA, Rukavishnikova SA, Titova ON, Akhmedov TA, Trofimov AV, Potemkin VV, Magen E.

Stem Cell Reviews and Reports · Volume Issue Year 2021
First published 2021-02-11 · PMID 33575961
DOI 10.1007/s12015-020-10087-6

Common issues and corresponding evidence

What research findings exist regarding Thymalin in immune regulation?+

Partial inflammation and coagulation-related indicators decreased faster after adding Thymalin.[1] ↗

Can Thymalin be used as a single well-defined sequence peptide?+

: Cannot determine based on name alone. Existing data involve thymus-derived peptide preparations and combination therapy; source, composition, and batch must be verified, and mixed extracts cannot be directly equated to a single peptide.[1] ↗

Thymalin—these conclusions apply to which study populations?+

Research on adjuvant therapy in COVID-19 patients and cellular mechanisms. Study design and co-treatment limitations; thymus extract mixtures are not equivalent to defined sequence peptides.[1] ↗

Thymalin

Return to catalog specifications and batch file verification entry.

↗